Renguo Guan
Department of Hepatobiliary Surgery,
Guangdong Provincial People's Hospital (Guangdong Provincial Academy of Medical Sciences),
Department of Hepatobiliary Surgery, Guangdong Provincial People's Hospital (Guangdong Provincial Academy of Medical Sciences)
Southern Medical University
Renguo Guan has not added Biography.
If you are Renguo Guan and would like to personalize this page please email our Author Liaison for assistance.
Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer.
Frontiers in oncology , 2019 | Pubmed ID: 31552163
Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival.
International journal of cancer Jul, 2020 | Pubmed ID: 31721169
Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival.
Annals of translational medicine Mar, 2020 | Pubmed ID: 32355831
Pan-cancer analysis of the CASP gene family in relation to survival, tumor-infiltrating immune cells and therapeutic targets.
Genomics Nov, 2020 | Pubmed ID: 32682809
Identification of Aberrantly Methylated Differentially CpG Sites in Hepatocellular Carcinoma and Their Association With Patient Survival.
Frontiers in oncology , 2020 | Pubmed ID: 32793465
A Comprehensive Exploration of the lncRNA CCAT2: A Pan-Cancer Analysis Based on 33 Cancer Types and 13285 Cases.
Disease markers , 2020 | Pubmed ID: 32908615
The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Journal of gastrointestinal oncology Dec, 2020 | Pubmed ID: 33457003
Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive Management.
Journal of oncology , 2022 | Pubmed ID: 35401743
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2022 | Pubmed ID: 36525610
Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed death-1 inhibitors.
International journal of surgery (London, England) Jul, 2024 | Pubmed ID: 38549220
Comparison of resection, ablation, and stereotactic body radiation therapy in treating solitary hepatocellular carcinoma ≤5 cm: a retrospective, multicenter, cohort study.
International journal of surgery (London, England) Jan, 2025 | Pubmed ID: 39093867
Hepatic arterial infusion chemotherapy-based conversion hepatectomy in responders versus nonresponders with hepatocellular carcinoma: a multicenter cohort study.
International journal of surgery (London, England) Jan, 2025 | Pubmed ID: 39166963
Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma.
British journal of cancer Mar, 2025 | Pubmed ID: 39748129
Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma.
Frontiers in immunology , 2024 | Pubmed ID: 39867887
Assessment of Tumor Burden Score as a Feasible and Reliable Tool for Prognosis Prediction for Hepatocellular Carcinoma Undergoing Hepatectomy: A Multicenter, Retrospective Study.
Journal of hepatocellular carcinoma , 2025 | Pubmed ID: 39959463
版权所属 © 2025 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。